Xenetic Biosciences XBIO
NASDAQ XBIO
$2.32 +0.06 (+2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Revenue (2011 - 2026)

Updated

Xenetic Biosciences (XBIO) recorded Revenue of $660,601 in Q2 2026, up 12.0% from $589,897 a year earlier but down 18.1% from the prior quarter.

Analysis

Xenetic Biosciences (XBIO) Revenue (2011 - 2026) Analysis & Trends

On a TTM basis, Xenetic Biosciences' Revenue came in at $3.26 million as of Jun 30, 2026, up 33.3% year-over-year; for FY2025, it came in at $2.98 million, up 19.0% from FY2024.

  • Annual Revenue has a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
  • Across earlier years, Revenue came in at $2.5 million in FY2024 (-1.6%), $2.54 million in FY2023 (+48.8%), $1.71 million in FY2022 (+47.1%) and $1.16 million in FY2021 (+165.6%).
  • Quarterly Revenue has ranged from $332,604 in Q4 2021 to $1.03 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Revenue has increased for four consecutive quarters, with growth averaging 16.0% over the last eight quarters.
  • Peak year-over-year performance for Revenue in the last five years was growth of 201.3% in Q3 2021, against a decline of 18.8% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $806,923 (Q1 2026), $766,296 (Q4 2025) and $1.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Xenetic Biosciences 5.44 Mn -20.39 Mn - 660,601.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 660,601.00
Mar 31, 2026 806,923.00
Dec 31, 2025 766,296.00
Sep 30, 2025 1.03 Mn
Jun 30, 2025 589,897.00
Mar 31, 2025 593,261.00
Dec 31, 2024 648,820.00
Sep 30, 2024 614,243.00
Jun 30, 2024 726,404.00
Mar 31, 2024 510,817.00
Dec 31, 2023 671,963.00
Sep 30, 2023 611,174.00
Jun 30, 2023 651,005.00
Mar 31, 2023 605,844.00
Dec 31, 2022 486,972.00
Sep 30, 2022 414,250.00
Jun 30, 2022 416,710.00
Mar 31, 2022 388,993.00
Dec 31, 2021 332,604.00
Sep 30, 2021 349,269.00
API Access

Xenetic Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=XBIO&period=max&api_key=YOUR_API_KEY